SEARCH

SEARCH BY CITATION

References

  • 1
    Heikkinen T. Influenza in children. Acta Paediatr 2006; 95:778784.
  • 2
    Hurwitz ES, Haber M, Chang A et al. Studies of the 1996–1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 2000; 182:12181221.
  • 3
    Heikkinen T, Silvennoinen H, Peltola V et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:13691373.
  • 4
    Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003; 36:299305.
  • 5
    Lahti E, Peltola V, Virkki R, Ruuskanen O. Influenza pneumonia. Pediatr Infect Dis J 2006; 25:160164.
  • 6
    Tsolia MN, Logotheti I, Papadopoulos NG et al. Impact of influenza infection in healthy children examined as outpatients and their families. Vaccine 2006; 34:59705976.
  • 7
    Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 2008; 6:114124.
  • 8
    Centers for Disease Control Prevention (CDC). Influenza vaccination coverage among children and adults – United States. 2008–09 influenza season. Morb Mortal Weekly Rep 2009; 58:10911095.
  • 9
    Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:3140.
  • 10
    Centers for Disease Control Prevention (CDC). Update: influenza activity, United States, August 30, 2009 – January 9, 2010. Morb Mortal Weekly Rep 2010; 59:3843.
  • 11
    Health Protection Agency. Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave. Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1258560552857.
  • 12
    Hayden FG, Atmar RL, Schilling M et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999; 341:13361343.
  • 13
    Peters PH Jr, Gravenstein S, Norwood P et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001; 49:10251031.
  • 14
    Dutkowski R, Thakrar B, Froehlich E, Suter P, Oo C, Ward P. Safety and pharmacology of oseltamivir in clinical use. Drug Saf 2003; 26:787801.
  • 15
    Chik KW, Li CK, Chan PK et al. Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: prospective observational study. Hong Kong Med J 2004; 10:103106.
  • 16
    Wallensten A, Oliver I, Lewis D, Harrison S. Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England. Euro Surveill 2009; 14:19285.